This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of cabergoline
PDMED_CABERGOLINE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
523 |
4. Check minimum number of events
Min. number of events
3
|
523 |
5. Include endpointsNone |
523 |
6. Filter based on genotype QC (FinnGen only) |
509 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Use of cabergoline
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 509 | 296 | 213 |
| Unadjusted period prevalence (%) | 0.10 | 0.10 | 0.10 |
| Median age at first event (years) | 46.95 | 39.42 | 57.41 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 523
- Matched controls
- 5230
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E22.1
ICD-10 Finland
Hyperprolactinaemia
2562.8
307.7
350
*
N04BC06
ATC
cabergoline; oral
+∞
307.7
523
*
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
957.3
307.7
293
7
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
238.9
307.7
213
15
G02CB01
ATC
bromocriptine; systemic
51.0
210.6
125
32
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
26.1
137.6
100
47
G20
ICD-10 Finland
Parkinson disease
29.9
136.8
94
38
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
30.4
136.1
93
37
N04BD01
ATC
selegiline; oral
54.6
123.3
71
15
H02AB09
ATC
hydrocortisone; systemic
25.5
115.6
84
39
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
29.9
65.4
44
16
G02CB03
ATC
cabergoline; oral
85.8
55.3
61
8
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
7.5
53.6
84
130
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
275.8
50.0
50
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
86.0
49.0
54
7
N04BC05
ATC
pramipexole; oral
6.4
48.7
90
165
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
68.0
48.3
55
9
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
+∞
44.4
42
*
N91.1
ICD-10 Finland
Secondary amenorrhoea
12.2
43.7
45
40
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
163.7
43.5
45
*
N04BX02
ATC
entacapone; oral
233.7
42.6
43
*
E23.00
ICD-10 Finland
Panhypopituitarism
155.8
41.4
43
*
N04BC04
ATC
ropinirole; oral
63.3
35.7
41
7
XCK00
NOMESCO Finland
Perimetry
5.4
29.7
62
126
N04BD02
ATC
rasagiline; oral
51.8
28.8
34
7
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
68.0
28.3
32
5
N87
ICPC
Parkinsonism
35.0
28.2
36
11
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
296.6
28.0
28
*
H03AA01
ATC
levothyroxine sodium; systemic
2.9
25.9
164
714
193
Kela drug reimbursment
Rasagiline
51.0
24.5
29
6
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
240.1
22.8
23
*
G02CB04
ATC
quinagolide; oral
+∞
22.0
21
*
N04AA02
ATC
biperiden; systemic
8.5
22.0
29
36
N03AE01
ATC
clonazepam; systemic
4.6
20.4
51
120
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
6.3
20.2
35
59
N06DA03
ATC
rivastigmine; oral, transdermal
5.9
18.9
35
63
N04BC01
ATC
bromocriptine; oral
+∞
17.8
17
*
N04BB01
ATC
amantadine; oral
14.7
17.0
28
20
N04BC02
ATC
pergolide; oral
+∞
15.7
15
*
D352, E221,
ICD-10 Finland
+∞
15.7
15
*
E23.05
ICD-10 Finland
Lack of TSH
77.2
13.6
15
*
G03DB01
ATC
dydrogesterone; oral
2.7
13.6
82
339
H01CB02
ATC
octreotide; parenteral
38.5
12.3
15
*
H01CB03
ATC
lanreotide; parenteral
38.5
12.3
15
*
2273A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)
+∞
11.5
11
*
ZXC86
NOMESCO Finland
Use of endoscopic device
35.9
11.3
14
*
E22.9
ICD-10 Finland
Hyperfunction of pituitary gland, unspecified
+∞
10.4
10
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.5
10.2
25
58
H02AA02
ATC
fludrocortisone; oral
12.5
9.9
17
14
N04BC09
ATC
rotigotine; transdermal
30.6
9.4
12
*
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
30.6
9.4
12
*
2542
FHL
Transasal hypophysectomy
+∞
9.4
9
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.7
8.5
48
191
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
8.5
95
510
E23.6
ICD-10 Finland
Other disorders of pituitary gland
91.5
8.4
9
*
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
91.5
8.4
9
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
8.1
8.4
18
23
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
17.5
8.1
12
7
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
22.4
8.0
11
5
N04AA01
ATC
trihexyphenidyl; oral
+∞
7.3
7
*
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
7.3
7
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.1
7.3
68
340
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
9.0
7.1
14
16
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
3.7
6.9
22
62
E21.0
ICD-10 Finland
Primary hyperparathyroidism
6.2
6.8
17
28
N30.9
ICD-10 Finland
Cystitis, unspecified
2.7
6.8
36
139
102
Kela drug reimbursment
Diabetes insipidus
40.6
6.8
8
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.3
6.7
49
221
E24.0
ICD-10 Finland
Pituitary-dependent Cushing disease
70.7
6.4
7
*
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
70.7
6.4
7
*
H53.4
ICD-10 Finland
Visual field defects
5.3
6.4
18
35
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
+∞
6.3
6
*
E23.08
ICD-10 Finland
Hypopituitarism
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
321
230
34.55
307.65
7.5
1.3
545.01
290.36
mu/l
2.36
309
209
304
376
17.92
257.58
4.6
1.9
365.38
373.80
nmol/l
0.29
296
349
164
159
14.57
156.59
1.9
1.3
6.19
9.81
u/l
2.08
134
131
157
328
6.41
76.12
6.2
2.2
11.43
12.94
nmol/l
1.39
149
302
82
98
9.74
65.27
1.6
1.6
0.36
0.39
nmol/l
0.15
64
83
124
265
5.82
57.58
1.8
1.4
13.70
23.20
iu/l
2.89
99
231
40
8
53.94
33.98
1.8
1.4
—
—
—
0
0
426
3168
2.86
20.08
6.9
3.9
14.75
14.55
pmol/l
0.88
413
2903
30
19
16.67
19.02
1.7
1.7
2.61
12.46
nmol/l
0.40
25
14
78
280
3.10
16.85
2.7
3.6
4.52
4.61
pmol/l
0.40
73
248
238
1578
1.93
12.05
6.1
5.8
1.22
1.21
mmol/l
0.46
226
1452
22
39
5.84
12.04
1.3
1.1
—
—
—
0
0
253
1756
1.85
10.74
7.1
6.6
1.22
1.21
mmol/l
0.81
214
1501
21
40
5.43
10.67
5.9
3.4
5.35
7.36
nmol/l
0.18
21
40
16
11
14.96
10.05
2.7
1.3
98.19
71.55
nmol/24h
0.44
16
11
439
3796
1.97
7.59
6.6
4.6
1.65
1.82
mu/l
2.96
415
3522
13
33
4.01
3.82
3.2
2.2
18.49
18.50
mu/l
0.00
13
33
60
371
1.70
3.40
3.0
3.1
—
—
—
0
0
448
4133
1.59
3.39
15.7
13.7
140.00
139.56
mmol/l
4.74
442
4008
10
25
4.06
3.10
1.7
1.6
—
—
—
0
0
447
4148
1.53
3.00
15.9
13.8
3.90
3.96
mmol/l
5.15
441
4012
195
1587
1.36
2.90
2.8
2.3
74.96
73.67
nmol/l
0.28
184
1456
265
2264
1.35
2.86
4.7
4.5
6.23
6.56
mmol/l
2.35
254
2062
41
245
1.73
2.65
6.9
3.9
100.85
82.87
ng/l
0.31
36
224
419
3865
1.42
2.65
12.5
11.1
87.98
87.58
ml/min/173m2
0.15
383
3143
47
294
1.66
2.58
2.8
2.2
7174.80
2638.36
u/l
0.43
16
128
12
47
2.59
2.28
1.4
1.3
—
—
—
0
0
333
3002
1.30
2.19
6.4
7.2
71.44
74.53
u/l
1.15
314
2827
6
14
4.32
2.15
2.0
1.4
50.50
69.54
ug/l
—
6
14
12
49
2.48
2.12
1.1
1.3
0.57
0.49
nmol/l
0.75
12
43
130
1041
1.33
2.06
3.1
2.8
0.23
0.30
e6/l
0.32
99
791
15
298
0.49
2.06
2.3
2.3
—
19.71
—
0
23
124
990
1.33
2.00
1.5
1.6
1.43
1.39
mmol/l
0.25
111
857
14
271
0.50
1.80
1.2
1.2
—
44.20
—
0
14
140
1166
1.27
1.64
3.1
2.9
103.74
108.69
e6/l
0.02
108
894
75
576
1.35
1.58
2.6
2.6
3.09
2.60
e6/l
0.19
47
314
169
1448
1.25
1.55
1.9
1.9
95.91
94.82
pmol/l
0.11
87
783
6
144
0.41
1.53
1.2
2.3
—
—
—
0
0
27
408
0.64
1.44
7.2
6.8
—
—
—
0
0
71
896
0.76
1.35
3.6
3.5
1.02
1.02
kg/l
—
9
127
102
845
1.26
1.25
1.4
1.5
20.41
20.16
nmol/l
0.05
92
736
382
3606
1.22
1.23
5.3
5.1
37.99
39.22
mmol/mol
2.02
363
3397
52
673
0.75
1.19
1.1
1.2
2.18
7.20
u/ml
1.99
17
269
63
496
1.31
1.15
2.4
2.4
22.64
24.24
%
0.44
55
436
22
143
1.56
1.13
1.3
1.5
—
—
—
0
0
54
685
0.76
1.09
1.2
1.3
28.18
26.67
iu/ml
0.05
12
223
7
33
2.14
1.06
1.0
1.5
79.29
75.18
umol/l
—
7
33
26
179
1.48
1.05
6.7
8.5
23.95
24.55
mmol/l
0.81
26
173
5
22
2.28
1.03
2.8
1.3
1.54
1.76
mmol/l
—
5
22
22
320
0.67
1.02
3.1
4.6
2.07
29.23
ug/l
1.09
15
264
0
29
0.00
0.98
0.0
1.2
—
—
—
0
0
11
186
0.58
0.97
1.5
2.0
—
—
—
0
0
29
396
0.72
0.96
1.5
1.9
—
—
—
0
0
11
63
1.76
0.90
2.1
2.1
13.55
13.10
%
0.75
11
63
12
71
1.71
0.89
2.8
2.3
16.40
16.04
%
—
5
34
8
44
1.83
0.86
1.8
1.1
—
—
—
0
0
53
427
1.27
0.85
4.9
3.9
32.90
31.04
%
0.65
48
302
132
1169
1.17
0.83
4.7
4.5
1.59
2.62
ug/l
1.96
119
1055
15
97
1.56
0.82
1.5
1.2
—
—
—
0
0
179
1626
1.15
0.81
11.9
12.0
1.22
1.19
inr
0.19
66
523
71
597
1.22
0.79
2.6
2.5
0.82
0.89
e6/l
0.07
43
333
133
1184
1.17
0.79
2.3
2.5
57.99
59.04
u/l
0.07
120
1107
5
100
0.50
0.78
1.0
1.3
—
37.02
—
0
8
11
173
0.63
0.76
1.3
3.4
24.05
24.55
mmol/l
0.17
11
168
216
1999
1.14
0.74
2.9
2.8
94.24
107.98
ug/l
0.53
203
1873
45
363
1.26
0.73
5.4
8.3
0.31
1.05
mmol/l
0.85
31
284
65
547
1.22
0.73
1.9
2.1
29.64
29.75
s
0.04
65
535
7
120
0.58
0.68
1.1
1.3
—
2.56
—
0
5
7
43
1.64
0.67
1.1
1.8
—
—
—
0
0
20
268
0.74
0.63
1.4
1.2
102.70
234.88
u/ml
0.75
20
242
12
79
1.53
0.63
3.2
3.8
4.36
4.42
e9/l
0.04
12
79
35
280
1.27
0.62
2.1
2.3
71.31
71.72
ml/min/173m2
0.02
15
118
24
183
1.33
0.60
1.3
1.6
—
—
—
0
0
12
80
1.51
0.60
3.6
4.2
59.58
57.45
%
0.33
12
80
10
150
0.66
0.59
1.1
1.5
1.38
1.18
g/l
—
10
142
213
1993
1.12
0.59
5.7
5.9
28.97
28.33
%
0.44
204
1888
0
23
0.00
0.58
0.0
3.1
—
—
—
0
0
166
1533
1.12
0.57
4.3
5.0
35.86
36.27
g/l
0.44
154
1439
77
676
1.16
0.56
3.0
3.4
890.04
264.12
ng/l
0.32
51
461
89
998
0.87
0.56
1.7
1.6
—
—
—
0
0
54
460
1.19
0.56
1.9
2.6
4.19
8.03
umol/l
3.93
45
395
5
90
0.55
0.56
4.8
1.6
—
—
—
0
0
23
295
0.77
0.56
1.2
1.5
—
—
—
0
0
42
501
0.82
0.55
1.7
2.0
—
—
—
0
0
19
142
1.35
0.55
1.8
1.6
—
—
—
0
0
9
60
1.51
0.54
2.2
1.4
—
—
—
0
0
210
1972
1.11
0.53
5.2
5.7
56.77
57.32
%
0.34
201
1868
21
162
1.31
0.50
1.6
1.3
—
—
—
0
0
6
41
1.47
0.50
1.3
1.1
—
—
—
0
0
35
290
1.22
0.49
5.3
7.5
7.57
8.93
mmol/l
0.72
35
275
7
108
0.64
0.49
1.4
1.5
—
—
—
0
0
133
1227
1.11
0.47
2.8
3.3
2.33
2.35
mmol/l
0.54
117
1098
16
209
0.76
0.46
1.6
1.6
—
—
—
0
0
14
103
1.37
0.45
2.4
1.5
—
—
—
0
0
76
847
0.88
0.45
2.1
2.2
—
—
—
0
0
84
930
0.88
0.45
3.0
3.1
836.07
1213.16
ng/l
0.95
72
769
181
1922
0.91
0.45
2.7
2.6
—
—
—
0
0
76
681
1.14
0.44
2.6
2.8
0.70
0.79
ug/l
0.48
47
419
72
644
1.14
0.43
1.7
1.7
1138.14
1168.34
nmol/l
0.10
58
493
69
769
0.88
0.41
1.7
1.7
449.70
12444210.93
pmol/l
0.50
61
667
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
3.6
—
—
—
0
0
0
16
0.00
0.41
0.0
3.6
—
—
—
0
0
15
114
1.33
0.41
1.3
2.0
298.93
350.14
ug/l
0.09
15
108
0
18
0.00
0.40
0.0
1.0
—
505.30
—
0
10
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
38.04
—
0
8
70
776
0.89
0.39
2.0
2.0
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
35.93
—
0
19
0
19
0.00
0.39
0.0
1.1
—
112.73
—
0
19
95
1033
0.90
0.38
4.3
3.9
6.30
10.88
mg/mmol
0.96
59
679
5
76
0.65
0.36
1.6
1.8
—
—
—
0
0
24
287
0.83
0.35
1.9
2.4
13.08
8.12
ug/l
0.29
19
261
91
986
0.91
0.35
2.4
2.6
338.19
6517.26
umol/l
3.96
79
877
58
644
0.89
0.34
2.5
2.8
2.45
2.43
mmol/l
0.55
45
555
17
137
1.25
0.32
1.6
1.8
—
—
—
0
0
106
988
1.09
0.32
2.2
2.0
2.61
2.86
mg/l
0.75
88
854
101
940
1.09
0.31
3.5
4.0
25.96
21.55
%
1.74
48
421
20
240
0.83
0.31
1.1
1.0
—
—
—
0
0
38
334
1.15
0.31
1.2
1.2
62.82
152.85
iu/ml
2.43
13
137
7
100
0.70
0.31
1.3
1.2
—
—
—
0
0
7
55
1.28
0.30
1.3
1.1
16.63
20.33
u/l
—
7
50
18
148
1.22
0.29
2.7
1.9
—
—
—
0
0
101
945
1.09
0.28
2.6
2.1
—
—
—
0
0
75
809
0.91
0.27
1.6
1.4
—
—
—
0
0
275
2671
1.06
0.27
4.5
4.1
—
3159.41
—
0
44
5
71
0.70
0.26
1.0
1.1
—
—
—
0
0
50
454
1.11
0.26
1.6
1.6
—
—
—
0
0
9
74
1.22
0.25
1.4
1.4
—
—
—
0
0
9
74
1.22
0.25
1.4
1.4
—
—
—
0
0
27
308
0.87
0.25
3.8
3.6
5.88
5.77
kpa
0.36
27
297
305
3122
0.94
0.24
3.5
3.5
—
—
—
0
0
40
443
0.89
0.24
1.5
1.5
—
—
—
0
0
6
81
0.74
0.24
1.2
1.2
—
—
—
0
0
7
92
0.76
0.22
3.1
1.6
—
—
—
0
0
435
4401
0.93
0.22
9.7
9.2
24.98
26.61
u/l
1.18
417
4267
33
296
1.12
0.22
6.6
6.2
1.16
1.26
mmol/l
0.42
33
287
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
395
4003
0.95
0.19
4.3
3.9
1.41
1.45
mmol/l
1.04
379
3764
210
2041
1.05
0.19
4.7
4.6
0.00
0.00
estimate
0.50
55
425
117
1123
1.05
0.17
3.1
3.1
8.51
7.96
mmol/l
0.41
106
968
104
995
1.06
0.17
1.3
1.3
1.65
1.45
u/ml
0.11
31
286
10
120
0.83
0.16
1.4
1.1
—
—
—
0
0
144
1394
1.05
0.15
2.5
3.3
31.55
31.22
u/l
0.02
137
1335
473
4698
1.07
0.15
20.7
18.3
40.69
40.46
%
0.40
450
4452
11
93
1.19
0.14
1.2
1.2
—
—
—
0
0
473
4699
1.07
0.14
20.9
18.4
253.09
252.44
e9/l
0.09
466
4601
208
2035
1.04
0.13
3.3
3.3
0.00
0.00
estimate
0.50
55
443
14
159
0.88
0.13
1.3
1.5
—
—
—
0
0
9
107
0.84
0.13
1.2
2.7
—
—
—
0
0
61
580
1.06
0.13
1.9
1.8
—
—
—
0
0
231
2352
0.97
0.12
7.7
8.9
4.00
4.08
e9/l
0.20
215
2078
473
4703
1.06
0.12
20.8
18.3
4.56
4.53
e12/l
0.67
466
4592
422
4188
1.04
0.11
12.5
12.6
21.50
21.59
mg/l
0.02
332
3282
294
2902
1.03
0.11
3.1
2.9
37.61
41.68
u/l
0.66
283
2750
399
4023
0.97
0.10
4.4
3.9
4.64
4.66
mmol/l
0.15
380
3799
17
187
0.91
0.10
1.5
1.7
—
—
—
0
0
473
4707
1.05
0.09
21.0
18.4
136.32
136.19
g/l
0.07
467
4645
10
87
1.15
0.09
3.1
1.6
0.85
0.89
nmol/l
—
10
77
114
1111
1.03
0.09
3.4
3.5
0.00
0.00
estimate
0.80
55
413
6
54
1.11
0.09
7.8
4.9
302.00
359.07
umol/l
—
6
48
405
4078
0.97
0.09
4.6
4.3
2.79
2.79
mmol/l
0.05
387
3824
6
56
1.07
0.08
2.5
1.4
—
—
—
0
0
6
56
1.07
0.08
2.5
1.4
—
—
—
0
0
6
56
1.07
0.08
2.5
1.4
—
—
—
0
0
24
257
0.93
0.08
1.4
1.5
—
—
—
0
0
6
57
1.05
0.08
2.5
1.4
—
—
—
0
0
6
57
1.05
0.08
2.5
1.4
—
—
—
0
0
6
57
1.05
0.08
2.5
1.4
—
—
—
0
0
5
62
0.80
0.08
1.0
2.2
—
1552.00
—
0
5
391
3883
1.03
0.08
4.4
4.0
5.69
5.83
mmol/l
1.89
365
3601
8
77
1.04
0.07
1.3
1.2
—
—
—
0
0
144
1415
1.02
0.07
2.7
3.5
23.91
39.27
ng/l
1.51
86
878
8
92
0.87
0.07
2.3
1.4
—
—
—
0
0
21
197
1.07
0.06
1.2
1.4
252.11
239.82
miu/ml
—
9
105
26
249
1.05
0.04
1.7
1.5
—
—
—
0
0
38
392
0.97
0.04
1.6
1.8
—
—
—
0
0
11
119
0.92
0.04
1.3
1.3
—
—
—
0
0
197
1986
0.99
0.03
5.4
6.0
9.20
11.14
umol/l
4.36
183
1881
10
92
1.09
0.03
2.4
1.3
412.80
406.78
mg/l
—
10
86
38
390
0.97
0.03
1.6
1.8
—
—
—
0
0
208
2067
1.01
0.02
3.4
3.3
0.00
0.00
estimate
-0.00
53
407
163
1641
0.99
0.02
3.4
3.4
—
—
—
0
0
37
362
1.02
0.01
2.1
2.3
26.52
30.87
u/l
0.94
29
304
22
213
1.03
0.01
1.5
1.7
—
—
—
0
0
24
234
1.03
0.00
1.5
1.5
—
—
—
0
0
23
236
0.97
0.00
1.3
1.4
—
—
—
0
0
23
236
0.97
0.00
1.3
1.4
—
—
—
0
0
12
124
0.97
0.00
4.8
2.2
—
—
—
0
0
13
134
0.97
0.00
1.2
1.1
—
—
—
0
0
13
134
0.97
0.00
1.2
1.1
—
—
—
0
0
23
235
0.98
0.00
1.3
1.4
—
—
—
0
0
23
235
0.98
0.00
1.3
1.4
—
—
—
0
0
27
266
1.02
0.00
1.3
1.3
—
—
—
0
0
91
913
1.00
0.00
1.6
1.8
1.06
1.06
mg/l
0.00
64
676
297
2975
1.00
0.00
3.6
3.8
9.79
10.58
mm/h
0.55
280
2759
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
5
53
0.94
-0.00
1.8
2.3
—
—
—
0
0
7
79
0.88
-0.00
1.6
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
9
93
0.97
-0.00
5.9
4.6
—
2.25
—
0
14
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
1.27
—
0
7
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
386
3860
1.00
-0.00
4.0
3.6
1.28
1.27
mmol/l
0.16
367
3612
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PDMED_CABERGOLINE – Use of cabergoline
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).